Dr. Mahesh Nawal Sexual Dysfunction Clinic Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 1.27%
(FY 2022)
- Profit 21.21%
(FY 2022)
- Ebitda 19.41%
(FY 2022)
- Net Worth 30.56%
(FY 2022)
- Total Assets 27.34%
(FY 2022)
About Dr. Mahesh Nawal Sexual Dysfunction Clinic
The Corporate was formerly known as Sexual Dysfunction Clinic & Research Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Aditya Nawal, Asha Nawal, and Mahesh Nawal serve as directors at the Company.
- CIN/LLPIN
U85110MP2010PTC023375
- Company No.
023375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dr. Mahesh Nawal Sexual Dysfunction Clinic?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Asha Nawal  | Director | 13-Apr-2010 | Current |
| Aditya Nawal | Director | 13-Apr-2010 | Current |
| Mahesh Nawal | Director | 21-Oct-2019 | Current |
Financial Performance of Dr. Mahesh Nawal Sexual Dysfunction Clinic.
Dr. Mahesh Nawal Sexual Dysfunction Clinic Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.27% increase. The company also saw a substantial improvement in profitability, with a 21.21% increase in profit. The company's net worth Soared by an impressive increase of 30.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Mahesh Nawal Sexual Dysfunction Clinic?
In 2021, Dr. Mahesh Nawal Sexual Dysfunction Clinic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Mahesh Nawal Sexual Dysfunction Clinic?
Unlock and access historical data on people associated with Dr. Mahesh Nawal Sexual Dysfunction Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Mahesh Nawal Sexual Dysfunction Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Mahesh Nawal Sexual Dysfunction Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
